This data adds to the primary analysis of the JUPITER study which demonstrated that CRESTOR (R) (rosuvastatin calcium) 20mg significantly reduced the risk of stroke by nearly half (48%; p=0.002), ...

Can u get crestor 20mg tablets usps This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Please note Crestor is also available in ...

The absence of a therapeutic for any drug or blockage thereof, should not be able to indicate that the cancer or combination is usually, effective, or appropriate for any licensed patient. If you have ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced results of the LUNAR (Limiting UNdertreatment of Lipids in Acute Coronary Syndrome with Rosuvastatin) study, which showed ...

WILMINGTON, Del., Feb. 8 AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has approved CRESTOR® (rosuvastatin calcium) to reduce the risk of stroke, myocardial ...

The FDA has approved Crestor (rosuvastatin calcium tablets, from AstraZeneca) to reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures in individuals without ...

Current international and national guidelines[2,3,4] continue to stress the significance of reducing LDL-cholesterol (LDL-C), an important risk factor for the development and progression of ...

Kyoto, Japan, Monday 29 September 2003. New data presented at the XIIIth International Symposium on Atherosclerosis (ISA) show AstraZeneca's highly effective statin CRESTOR (rosuvastatin) achieves ...

A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared to placebo among men and women with ...

Orlando, Florida, November 17 (ots/PRNewswire)-JUPITER, which used CRESTOR 20 mg, is the first statin study to demonstrate a reduction in the risk of cardiovascular (CV) events in women without ...

SAN DIEGO, Feb. 19 /PRNewswire-FirstCall/ -- A new analysis from the JUPITER study presented today at the International Stroke Conference (ISC) in San Diego ...